SCHEMBL7449263

SCHEMBL7449263

CC(C)(C)ON(C=O)C(CC(F)(F)F)C(=O)C(=O)NCc1cccc([N+](=O)[O-])c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 1/20 0.44
OPRK1 P41145 1/20 0.44
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
RECQL P46063 1/20 0.41
PTPN1 P18031 3/20 0.40
ALDH1A1 P00352 3/20 0.39
KDM4E B2RXH2 1/20 0.39
NNMT P40261 1/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
GABRP O00591 1/20 0.38
GABRD O14764 1/20 0.38
GABRA1 P14867 1/20 0.38
GABRB1 P18505 1/20 0.38
GABRG2 P18507 1/20 0.38
GABRB3 P28472 1/20 0.38
GABRA5 P31644 1/20 0.38
GABRA3 P34903 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7449281 1.00 OPRM1 (0.44) OPRM1OPRK1CYP2D6CYP2C9CYP2C19
SCHEMBL7440856 0.89 L3MBTL1 (0.40) CYP2C9CYP2C19ALDH1A1MEN1KMT2A
SCHEMBL7440833 0.89 L3MBTL1 (0.40) CYP2C9CYP2C19ALDH1A1MEN1KMT2A
SCHEMBL7443186 0.86 ALDH1A1 (0.43) CYP2D6CYP2C9ALDH1A1KDM4EMEN1
SCHEMBL7443195 0.86 ALDH1A1 (0.43) CYP2D6CYP2C9ALDH1A1KDM4EMEN1
SCHEMBL7438937 0.83 OPRM1 (0.43) OPRM1OPRK1CYP2D6CYP2C9CYP2C19
SCHEMBL7437324 0.78 CTSK (0.33) ALDH1A1MEN1KMT2AMAPT
SCHEMBL7449272 0.77 CTSK (0.52) OPRM1OPRK1CYP2D6CYP2C9CYP2C19
SCHEMBL7433110 0.72
SCHEMBL7433115 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6187905-B1 PEPTIDE COMPOUND WHICH INHIBITS VIRAL PROTEINASES; VIRICIDES FOR HEPATITIS C, HEPATITIS G, AND HUMAN GB VIRUSES HOFFMANN-LA ROCHE INC. 2001-02-13 US disclosed